Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -161,966 | -121,441 | -82,939 | -175,149 | -121,175 |
| Depreciation Amortization | 46,304 | 31,386 | 14,616 | 45,738 | 32,291 |
| Income taxes - deferred | -341 | -984 | -520 | N/A | N/A |
| Accounts receivable | -36,871 | -18,574 | -11,856 | -17,292 | -15,497 |
| Accounts payable and accrued liabilities | 16,279 | 25,725 | -2,216 | 33,076 | 16,603 |
| Other Working Capital | -45,127 | -15,009 | -32,994 | -911 | -24,369 |
| Other Operating Activity | 95,368 | 41,689 | 41,755 | 45,598 | 44,058 |
| Operating Cash Flow | $-86,354 | $-57,208 | $-74,154 | $-68,940 | $-68,089 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 845,201 | -63,913 | -30,405 | -613,720 | -674,375 |
| PPE Investments | -130,970 | -79,448 | -10,657 | -150,093 | -97,987 |
| Net Acquisitions | N/A | N/A | N/A | -17,908 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -135 |
| Other Investing Activity | -530 | -380 | -140 | -578 | -135 |
| Investing Cash Flow | $713,701 | $-143,741 | $-41,202 | $-782,299 | $-772,497 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 729,477 | 729,479 | 729,536 | 896,430 | 896,431 |
| Debt Repayment | -493,356 | -493,356 | -493,355 | N/A | -4,678 |
| Common Stock Issued | 10,526 | 9,135 | 3,650 | 11,531 | 9,039 |
| Other Financing Activity | -90 | 319 | 295 | 26,181 | 23,996 |
| Financing Cash Flow | $246,557 | $245,577 | $240,126 | $934,142 | $924,788 |
| Exchange Rate Effect | N/A | N/A | N/A | 36 | 12 |
| Beginning Cash Position | 160,430 | 160,430 | 160,430 | 77,491 | 77,491 |
| End Cash Position | 1,034,334 | 205,058 | 285,200 | 160,430 | 161,705 |
| Net Cash Flow | $873,904 | $44,628 | $124,770 | $82,939 | $84,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,354 | -57,208 | -74,154 | -68,940 | -68,089 |
| Capital Expenditure | -130,970 | -79,448 | -10,657 | -150,093 | -97,987 |
| Free Cash Flow | -217,324 | -136,656 | -84,811 | -219,033 | -166,076 |